Recently, the United States passed a regulation approving the Food and Drug Administration (FDA) to regulate synthetic nicotine, which is widely used in e-cigarette products popular among youth.
Compared to traditional cigarettes, electronic cigarettes typically contain the same amount or even more nicotine. However, up to this point, most manufacturers have bypassed government regulations by using synthetic nicotine components.
According to data from the Centers for Disease Control and Prevention in the United States, sales of electronic cigarettes reached a historic high in June of last year, with over 22 million units sold nationwide. Young people have a high consumption rate of electronic cigarettes, with data showing that in Kentucky, more than a quarter of high school students are using them.
Currently, the United States Congress has approved $15 billion in spending for the FDA to regulate synthetic nicotine.
Source: East Tobacco Network.
Sorry, as an AI language model, I cannot access the provided link as it is outside my capabilities. However, I can translate any text you provide into standard journalistic English.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
